BAC
Bank of America Corporation
BAC has the edge over MSBI overall, supported by stronger valuation and stronger fundamentals.
MSBI
Midland States Bancorp, Inc.
MSBI's outlook is improving despite an expensive valuation.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
MSBI Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| N/A | |
| N/A |
MSBI's profitability is currently healthy, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like MSBI.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC has the edge over MSBI in the historical PE scenario, which offers more potential upside but is not a forecast.
MSBI PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 6.7x | $15.25 | -52% |
| Fair | 8.8x | $20.08 | -37% |
| Forward | 9.1x | $31.72 | — |
| Current | 14x | $31.72 | — |
| Expensive | 16x | $36.37 | +15% |
Historical ranges are pointers, not guarantees.
MSBI's PE is in its expensive range at 14x. If earnings grow as analysts expect, today's price would be 9.1x next year's earnings, in its fair range.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for BAC, with profitability improving.
MSBI Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for MSBI, with profitability improving.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC has the stronger earnings trend. Trailing diluted EPS is up 14% for BAC versus MSBI up 14%.
MSBI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.47 | +51% |
| Q3 2024 | $2.01 | -46% |
| Q2 2024 | $1.98 | -51% |
| Q1 2024 | $2.64 | -37% |
| Q4 2023 | $2.97 | -30% |
| Q3 2023 | $3.73 | -5.6% |
| Q2 2023 | $4.06 | +7.7% |
| Q1 2023 | $4.17 | +13% |
| Q4 2022 | $4.23 | +18% |
MSBI's earnings per share have fallen from their peak: $2.29 over the past year, against $4.23 in late 2022.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC has the edge over MSBI on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC's operating margin was 30% last quarter, down 3.7 points from the same quarter a year ago.
MSBI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $86M | +5.9% |
| Q2 2026 | $83.4M | +1.4% |
| Q1 2026 | $79.5M | +4.6% |
| Q4 2025 | $85.6M | -8.9% |
| Q3 2025 | $81.1M | +9.2% |
| Q2 2025 | $82.2M | +13% |
| Q1 2025 | $76.1M | -1.4% |
| Q4 2024 | $93.9M | +31% |
MSBI's revenue grew through 2024 and has held roughly level since: $86M last quarter, up 5.9% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 34% | +20 points |
| Q2 2026 | 31% | +13 points |
| Q1 2026 | 30% | +212 points |
| Q4 2025 | -3.8% | +38 points |
| Q3 2025 | 14% | -16 points |
| Q2 2025 | 18% | +6.5 points |
| Q1 2025 | -181% | -205 points |
| Q4 2024 | -41% | -70 points |
MSBI has the edge over BAC on profitability, with a higher operating margin.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC has the edge over MSBI on cash flow, with more consistent year-over-year improvement.
MSBI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $37.9M | -52% |
| Q2 2026 | $29.2M | +9.5% |
| Q1 2026 | $16.3M | -28% |
| Q4 2025 | -$7.8M | -115% |
| Q3 2025 | $78.6M | +153% |
| Q2 2025 | $26.7M | +61% |
| Q1 2025 | $22.9M | -13% |
| Q4 2024 | $52.8M | -38% |
MSBI's free cash flow was $76M over the past year, down 58% from the year before. Free cash flow isn't a meaningful measure for financial services companies like MSBI.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over MSBI on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
MSBI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +65.5K shares |
| 1 year | -3.3% | -724K shares |
| 3 years | -3.8% | -837K shares |
| 5 years | -6.4% | -1.4M shares |
| Available history | -14% | -3.4M shares |
MSBI has 21M diluted shares, down 3.3% from a year ago, with $20M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $11,000 |
| Q2 2026 | $2.7M |
| Q1 2026 | $7.9M |
| Q4 2025 | $9.7M |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $29,000 |
MSBI spent $20M buying back its own shares over the past year, more than ten times what it spent the year before.
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
MSBI Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 5.2x | High |
| Q2 2026 | -0.1x | Net Cash |
| Q1 2026 | 5.6x | High |
| Q4 2024 | 16.1x | High |
| Q3 2024 | 5.1x | High |
| Q2 2024 | 6.7x | High |
| Q1 2024 | 3.7x | Elevated |
| Q4 2023 | 4.0x | High |
MSBI has the edge over BAC on leverage, with a lower net debt burden relative to earnings.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
MSBI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 55.6 | Neutral |
| Stochastic | 23.0 | Neutral |
MSBI's weekly RSI is 56 (neutral) and its Stochastic is 23 (neutral).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC has the edge over MSBI on valuation relative to its sector.
MSBI PE vs Financial Services Sector
| Metric | MSBI | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 6.4% above |
| PE % | 79 | 63 | 16 pts above |
MSBI is trading at 14x earnings, in line with the Financial Services sector's median of 13x.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
MSBI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $32.5 | 2.4% below |
| 20 week MA | $32.6 | 2.6% below |
| 50 week MA | $27.5 | 15% above |
| 100 week MA | $22.8 | 39% above |
| 200 week MA | $23.0 | 38% above |
MSBI has the edge over BAC on trend strength, trading above more of its moving averages.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has finished higher in four of the last six years. It's down 10% so far in 2026.
MSBI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $29.0 | $17.5 | -40% |
| 2021 | $17.5 | $25.0 | +43% |
| 2022 | $25.0 | $26.5 | +6.2% |
| 2023 | $26.5 | $27.6 | +3.9% |
| 2024 | $27.6 | $24.4 | -11% |
| 2025 | $24.4 | $21.2 | -13% |
| 2026 YTD | $21.2 | $31.7 | +50% |
MSBI has the edge over BAC on returns for 2026, with the stronger performance.